New approaches to the treatment of onychomycosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8391029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to review the pharmacologic properties of two newer agents, itraconazole and terbinafine, and to assess their clinical efficacy in onychomycosis. Both drugs are effective in treating infections caused by dermatophytes. Itraconazole appears to be more efficacious in infections caused by Candida species. The improved effectiveness of these agents is probably related to their rapid penetration into the nails and prolonged bioavailability at the site of infection.
Medical subject headings
- Antifungal Agents
- Ketoconazole
- Naphthalenes
- Onychomycosis